Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography.
This map shows the geographic impact of A Guillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Guillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Guillard more than expected).
This network shows the impact of papers produced by A Guillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Guillard. The network helps show where A Guillard may publish in the future.
Co-authorship network of co-authors of A Guillard
This figure shows the co-authorship network connecting the top 25 collaborators of A Guillard.
A scholar is included among the top collaborators of A Guillard based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A Guillard. A Guillard is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Logak, M., et al.. (1996). [Contribution of position emission tomography in a case of Marchiafava Bignami disease: Morel's laminar sclerosis?].. PubMed. 152(1). 47–50.5 indexed citations
Angelard, B., et al.. (1993). [Abnormal movements of the larynx. Diagnostic approach and therapeutic perspectives].. PubMed. 110(3). 125–8.1 indexed citations
Reignier, Arnaud, et al.. (1989). [Remission of Lambert-Eaton syndrome over a 10-year period. Recurrence without evidence of tumor at autopsy].. PubMed. 145(12). 851–2.3 indexed citations
12.
Mahieux, Florence, et al.. (1988). [Hypoprothrombinemia under cefotaxime during a vitamin K-deficient diet].. PubMed. 17(21). 1095–1095.1 indexed citations
13.
Fenelon, Guilherme, et al.. (1987). [Isolated meningoencephalitis in Lyme disease].. PubMed. 138(2). 149–50.1 indexed citations
14.
Guillard, A, et al.. (1984). [Polyradiculoneuritis in a developmental flare-up of Behçet's disease].. PubMed. 140(8-9). 520–2.5 indexed citations
15.
Guillard, A & C Chastang. (1979). Application of 5 HTP in the treatment of essential tremor.. PubMed. 13(1-4). 251–3.1 indexed citations
16.
Guillard, A, et al.. (1978). [Long-term prognostic factors in Parkinson's disease (author's transl)].. PubMed. 134(5). 341–54.9 indexed citations
17.
Goldstein, Bram H., et al.. (1977). [Syringomyelic syndrome with tuberculous meningitis (apropos of 4 cases)].. PubMed. 133(12). 697–708.5 indexed citations
Boudin, G, et al.. (1972). [Friedreich's disease with supramedullary systematized lesions].. PubMed. 127(4). 441–56.5 indexed citations
20.
Boudin, G, et al.. (1972). [Indications and results of monoamine treatment in parkinsonian syndromes].. PubMed. 127(1). 79–97.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.